235 related articles for article (PubMed ID: 25818187)
1. The S6K protein family in health and disease.
Tavares MR; Pavan IC; Amaral CL; Meneguello L; Luchessi AD; Simabuco FM
Life Sci; 2015 Jun; 131():1-10. PubMed ID: 25818187
[TBL] [Abstract][Full Text] [Related]
2. Nucleocytoplasmic localization of p70 S6K1, but not of its isoforms p85 and p31, is regulated by TSC2/mTOR.
Rosner M; Hengstschläger M
Oncogene; 2011 Nov; 30(44):4509-22. PubMed ID: 21602892
[TBL] [Abstract][Full Text] [Related]
3. Different interactomes for p70-S6K1 and p54-S6K2 revealed by proteomic analysis.
Pavan IC; Yokoo S; Granato DC; Meneguello L; Carnielli CM; Tavares MR; do Amaral CL; de Freitas LB; Paes Leme AF; Luchessi AD; Simabuco FM
Proteomics; 2016 Oct; 16(20):2650-2666. PubMed ID: 27493124
[TBL] [Abstract][Full Text] [Related]
4. Distinct Roles of mTOR Targets S6K1 and S6K2 in Breast Cancer.
Sridharan S; Basu A
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32054043
[TBL] [Abstract][Full Text] [Related]
5. Clinical potential of the mTOR targets S6K1 and S6K2 in breast cancer.
Pérez-Tenorio G; Karlsson E; Waltersson MA; Olsson B; Holmlund B; Nordenskjöld B; Fornander T; Skoog L; Stål O
Breast Cancer Res Treat; 2011 Aug; 128(3):713-23. PubMed ID: 20953835
[TBL] [Abstract][Full Text] [Related]
6. p70 S6K1 nuclear localization depends on its mTOR-mediated phosphorylation at T389, but not on its kinase activity towards S6.
Rosner M; Schipany K; Hengstschläger M
Amino Acids; 2012 Jun; 42(6):2251-6. PubMed ID: 21710263
[TBL] [Abstract][Full Text] [Related]
7. [Research on progress and prospect of kinase S6K1].
Zhang H; Liang J; Zhang J
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2014 Aug; 31(4):935-8, 949. PubMed ID: 25464817
[TBL] [Abstract][Full Text] [Related]
8. Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance.
Khamzina L; Veilleux A; Bergeron S; Marette A
Endocrinology; 2005 Mar; 146(3):1473-81. PubMed ID: 15604215
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of insulin signaling and adipogenesis by rapamycin: effect on phosphorylation of p70 S6 kinase vs eIF4E-BP1.
El-Chaâr D; Gagnon A; Sorisky A
Int J Obes Relat Metab Disord; 2004 Feb; 28(2):191-8. PubMed ID: 14970836
[TBL] [Abstract][Full Text] [Related]
10. Revealing Different Roles of the mTOR-Targets S6K1 and S6K2 in Breast Cancer by Expression Profiling and Structural Analysis.
Karlsson E; Magić I; Bostner J; Dyrager C; Lysholm F; Hallbeck AL; Stål O; Lundström P
PLoS One; 2015; 10(12):e0145013. PubMed ID: 26698305
[TBL] [Abstract][Full Text] [Related]
11. Endotoxin disrupts the leucine-signaling pathway involving phosphorylation of mTOR, 4E-BP1, and S6K1 in skeletal muscle.
Lang CH; Frost RA
J Cell Physiol; 2005 Apr; 203(1):144-55. PubMed ID: 15389631
[TBL] [Abstract][Full Text] [Related]
12. Regulation and localization of ribosomal protein S6 kinase 1 isoforms.
Kim D; Akcakanat A; Singh G; Sharma C; Meric-Bernstam F
Growth Factors; 2009 Feb; 27(1):12-21. PubMed ID: 19085255
[TBL] [Abstract][Full Text] [Related]
13. Ribosomal protein S6 kinase1 coordinates with TOR-Raptor2 to regulate thylakoid membrane biosynthesis in rice.
Sun L; Yu Y; Hu W; Min Q; Kang H; Li Y; Hong Y; Wang X; Hong Y
Biochim Biophys Acta; 2016 Jul; 1861(7):639-49. PubMed ID: 27102613
[TBL] [Abstract][Full Text] [Related]
14. S6 kinase signaling: tamoxifen response and prognostic indication in two breast cancer cohorts.
Bostner J; Karlsson E; Eding CB; Perez-Tenorio G; Franzén H; Konstantinell A; Fornander T; Nordenskjöld B; Stål O
Endocr Relat Cancer; 2015 Jun; 22(3):331-43. PubMed ID: 25972244
[TBL] [Abstract][Full Text] [Related]
15. eIF3 controls cell size independently of S6K1-activity.
Schipany K; Rosner M; Ionce L; Hengstschläger M; Kovacic B
Oncotarget; 2015 Sep; 6(27):24361-75. PubMed ID: 26172298
[TBL] [Abstract][Full Text] [Related]
16. Insulin activation of vacuolar protein sorting 34 mediates localized phosphatidylinositol 3-phosphate production at lamellipodia and activation of mTOR/S6K1.
Hirsch DS; Shen Y; Dokmanovic M; Yu J; Mohan N; Elzarrad MK; Wu WJ
Cell Signal; 2014 Jun; 26(6):1258-68. PubMed ID: 24582588
[TBL] [Abstract][Full Text] [Related]
17. Metformin sensitizes human bladder cancer cells to TRAIL-induced apoptosis through mTOR/S6K1-mediated downregulation of c-FLIP.
Zhang T; Wang X; He D; Jin X; Guo P
Anticancer Drugs; 2014 Sep; 25(8):887-97. PubMed ID: 24714080
[TBL] [Abstract][Full Text] [Related]
18. Paradigm of kinase-driven pathway downstream of epidermal growth factor receptor/Akt in human lung carcinomas.
Dobashi Y; Suzuki S; Kimura M; Matsubara H; Tsubochi H; Imoto I; Ooi A
Hum Pathol; 2011 Feb; 42(2):214-26. PubMed ID: 21040950
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical analysis of the mammalian target of rapamycin signalling pathway in extramammary Paget's disease.
Chen S; Nakahara T; Uchi H; Takeuchi S; Takahara M; Kido M; Dugu L; Tu Y; Moroi Y; Furue M
Br J Dermatol; 2009 Aug; 161(2):357-63. PubMed ID: 19438435
[TBL] [Abstract][Full Text] [Related]
20. Embelin inhibits growth and induces apoptosis through the suppression of Akt/mTOR/S6K1 signaling cascades.
Kim SW; Kim SM; Bae H; Nam D; Lee JH; Lee SG; Shim BS; Kim SH; Ahn KS; Choi SH; Sethi G; Ahn KS
Prostate; 2013 Feb; 73(3):296-305. PubMed ID: 22887478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]